We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Design and Testing – News and Features

News

Oxford Gene Technology Joins Chavi Funded Project to Provide Microarrays for HIV Vaccine Research

OGT has been selected to design and fabricate microarrays for the Innate Discovery Team as part of the Centre for HIV-AIDS Vaccine Immunology research project to develop vaccines for HIV.
News

Bellicum Announces Commercial Licensing of Ariad's ARGENT™

Bellicum announces licensing agreement with Ariad for development of new cancer therapies.
News

Keystone Symposia Expands Global Health Conference Series

Bill & Melinda Gates Foundation supports series with grant of $2.5 million.
News

Cytodyn Offers Latest Info for Advanced Bird Flu Protection

The site includes updated information about developments in HIV medication and other infectious disease issues.
News

Pepscan Secures Euro 7 Million in its Second Financing Round

Company also launches its phase I/II GNRH vaccine trial for the treatment of hormone dependant prostate cancer.
News

NHGRI Announces Latest Sequencing Targets

Comparing the genomes of other species to humans is a tool to help researchers understand the working parts of the human genome.
News

BioSilicon™ Demonstrates Adjuvant Properties Potential to be Exploited in Delivery of Vaccines

The BioSilicon™-antigen combinations resulted in an enhanced immune response based on in vivo antibody responses.
News

CHAVI Announces International Search for Genes Affecting HIV Response

Investigators who once competed to unravel the mysteries of HIV will share access to patient groups, they have studied.
News

Carrington Receives European Patent Protection for Stabilization of Proteins and Peptides

Focuses on stabilization of unstable molecules expands drug delivery base for proteins and peptides.
News

CytoGenix Announces Collaboration with USDA Agricultural Research Service

CytoGenix scientists will work with a team of USDA scientists to develop synDNA™ vaccines for brucellosis dieses.
Advertisement